Top Institutions in Ophthalmology and Artificial Intelligence in Diabetic Retinopathy Screening
Institutions leading in this area combine expertise in ophthalmology, AI/machine learning, and population health screening programs. They conduct large-scale validation studies, develop AI algorithms with regulatory approvals, and implement real-world screening programs integrating AI with human grading workflows.
-
#1
Moorfields Eye Hospital NHS Foundation Trust
London, England
Moorfields is a global leader in ophthalmic research and clinical care, pioneering AI integration in diabetic retinopathy screening, and collaborating closely with the NHS Diabetic Eye Screening Programme.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
This institution is renowned for its cutting-edge research in ophthalmic imaging and AI algorithm development, contributing to FDA-approved AI systems for diabetic retinopathy detection.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong track record in clinical research on diabetic retinopathy and is advancing AI applications for screening in diverse populations.
-
#4
Stanford University School of Medicine
Stanford, CA
Stanford is a leader in AI research and has developed several deep learning models for retinal disease detection, contributing to the advancement of automated diabetic retinopathy screening.
-
#5
National Health Service (NHS) Diabetic Eye Screening Programme
London, England
As one of the largest systematic diabetic retinopathy screening programs globally, NHS DESP has been a model for integrating AI-assisted screening at population scale with robust quality assurance.
